Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.16 USD | -1.36% | -4.02% | +7.57% |
Dec. 04 | Kenvue Inc. Presents at Morgan Stanley Global Consumer & Retail Conference, Dec-04-2024 11:45 AM | |
Nov. 20 | BNP Paribas Exane Lifts Price Target on Kenvue to $24 From $22 | MT |
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 14.32B | 14.47B | 15.05B | 14.95B | 15.44B |
Total Revenues | 14.32B | 14.47B | 15.05B | 14.95B | 15.44B |
Cost of Goods Sold, Total | 6.63B | 6.58B | 6.59B | 6.61B | 6.8B |
Gross Profit | 7.69B | 7.88B | 8.47B | 8.34B | 8.64B |
Selling General & Admin Expenses, Total | 5.15B | 4.91B | 5.42B | 5.38B | 5.68B |
Other Operating Expenses | -31M | -80M | -78M | -28M | 18M |
Other Operating Expenses, Total | 5.12B | 4.83B | 5.34B | 5.35B | 5.7B |
Operating Income | 2.57B | 3.05B | 3.13B | 2.99B | 2.94B |
Interest Expense, Total | - | - | - | - | -358M |
Interest And Investment Income | - | - | - | - | 108M |
Net Interest Expenses | - | - | - | - | -250M |
Currency Exchange Gains (Loss) | -60M | -40M | -20M | -42M | -58M |
Other Non Operating Income (Expenses) | 59M | 3M | 25M | 11M | -5M |
EBT, Excl. Unusual Items | 2.57B | 3.02B | 3.13B | 2.96B | 2.63B |
Restructuring Charges | -122M | -66M | -117M | -100M | - |
Gain (Loss) On Sale Of Investments | 275M | - | - | - | - |
Gain (Loss) On Sale Of Assets | - | - | - | - | 9M |
Asset Writedown | -51M | - | - | -12M | - |
Legal Settlements | -553M | -3.97B | -92M | 7M | -26M |
Other Unusual Items | - | - | - | -213M | -423M |
EBT, Incl. Unusual Items | 2.12B | -1.02B | 2.92B | 2.64B | 2.19B |
Income Tax Expense | 685M | -137M | 894M | 550M | 526M |
Earnings From Continuing Operations | 1.44B | -879M | 2.03B | 2.09B | 1.66B |
Net Income to Company | 1.44B | -879M | 2.03B | 2.09B | 1.66B |
Net Income - (IS) | 1.44B | -879M | 2.03B | 2.09B | 1.66B |
Net Income to Common Incl Extra Items | 1.44B | -879M | 2.03B | 2.09B | 1.66B |
Net Income to Common Excl. Extra Items | 1.44B | -879M | 2.03B | 2.09B | 1.66B |
Per Share Items | |||||
Net EPS - Basic | - | - | - | - | 0.9 |
Basic EPS - Continuing Operations | - | - | - | - | 0.9 |
Basic Weighted Average Shares Outstanding | - | - | - | - | 1.85B |
Net EPS - Diluted | - | - | - | - | 0.9 |
Diluted EPS - Continuing Operations | - | - | - | - | 0.9 |
Diluted Weighted Average Shares Outstanding | - | - | - | - | 1.85B |
Normalized Basic EPS | - | - | - | - | 0.89 |
Normalized Diluted EPS | - | - | - | - | 0.89 |
Dividend Per Share | - | - | - | - | 0.4 |
Payout Ratio | - | - | - | - | 874.64 |
Supplemental Items | |||||
EBITDA | 3.28B | 3.8B | 3.86B | 3.63B | 3.57B |
EBITA | 2.92B | 3.47B | 3.54B | 3.33B | 3.26B |
EBIT | 2.57B | 3.05B | 3.13B | 2.99B | 2.94B |
EBITDAR | 3.35B | 4.02B | 4.04B | 3.78B | 3.62B |
Effective Tax Rate - (Ratio) | 32.31 | 13.48 | 30.56 | 20.86 | 24.02 |
Current Domestic Taxes | 264M | 308M | 8M | 75M | 266M |
Current Foreign Taxes | 324M | 356M | 318M | 318M | 374M |
Total Current Taxes | 588M | 664M | 326M | 393M | 640M |
Deferred Domestic Taxes | 204M | -741M | 627M | 205M | -39M |
Deferred Foreign Taxes | -107M | -60M | -59M | -48M | -75M |
Total Deferred Taxes | 97M | -801M | 568M | 157M | -114M |
Normalized Net Income | 1.61B | 1.89B | 1.96B | 1.85B | 1.64B |
Interest on Long-Term Debt | - | - | - | - | 338M |
Non-Cash Pension Expense | - | - | - | 7M | 9M |
Supplemental Operating Expense Items | |||||
Advertising Expense | 1.26B | 1.16B | 1.38B | 1.36B | 1.35B |
Selling and Marketing Expenses | 1.26B | 1.16B | 1.38B | 1.36B | 1.35B |
Research And Development Expense From Footnotes | 391M | 320M | 355M | 375M | 399M |
Net Rental Expense, Total | 68M | 219M | 180M | 152M | 48M |
Imputed Operating Lease Interest Expense | - | - | - | - | 32.18M |
Imputed Operating Lease Depreciation | - | - | - | - | 15.82M |
Stock-Based Comp., COGS (Total) | - | - | - | 30M | 67M |
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | 107M | 121M |
Stock-Based Comp., Other (Total) | 102M | 115M | 141M | - | - |
Total Stock-Based Compensation | 102M | 115M | 141M | 137M | 188M |